Company type
Developer of medicines for treating skin diseases caused by resistant microbes.Funding rounds
Series C USD 14,000,000
USD 14,000,000 ( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Perceptive Advisors | Led the round. | ||
|
Romulus Capital | Early stage venture capital fund founded out of MIT. | Initial investment. | |
|
|
Aarin Capital | Follow-on investment. | ||
|
Kalaari Capital | Follow-on investment. | ||
|
|
Sabre Partners | Follow-on investment. |
Investment activity status
Active investor